Volteface Team

On 5th September, the first patient entered the University Hospital 12 de Octubre in Spain as part of an independent clinical trial researching the efficacy of cannabis as a treatment …

A new report has revealed that approximately 29.6 million people (50.2%) in the UK could be entitled to a medicinal cannabis prescription, yet just 0.048% of the population has been …

This month, medicinal cannabis organisation Cancard announced a collaborative project with Grow Lab Organics to enable a licensed medicinal cannabis farm to become a community owned endeavour, the first of …

Volteface and The Medical Cannabis Clinicians Society (MCCS) have been successfully elected as the new secretariat for the medical cannabis on prescription APPG – bringing new bold strategy and commitment …

On 12th April 2023, Minister of Health, Dr. Karl Lauterbach, and Federal Minister of Food and Agriculture, Cem Özdemir, held a press conference to announce the  updated German approach to legalised adult …

Medical cannabis was legalised in the UK on 1st November 2018, following years of extensive campaigning. However, over half of the British public are still unaware that they can legally …

Yesterday, the UK government confirmed plans to ban nitrous oxide or NOS, and reschedule it as a Class C drug, ignoring the advice of the its own Advisory Council on the …

After taking some time off due to becoming a father, Clark French, founder of the United Patients Alliance, is relaunching the patient-focused organisation at the Brighton Medicinal Cannabis Summit 2023. …

The UK’s largest medical cannabis company has announced a new capital raise and the completion of an internal restructure.  This new raise will support Lyphe Group to become cash flow …

The potential of cannabis medicines to treat symptoms of epilepsy, especially for children who are resistant to other available drugs, has been one of the driving forces behind the liberalisation …